ARTL ▼ -2.5% - Artelo Biosciences, Inc. $ARTL - Artelo Biosciences to Present ART27.13 Data Demonstrating Potential to Treat Chemotherapy-Induced Neuropathic Pain at the IASP 2026 World Congress on Pain 29-OCT-2026 09:00 AM ET